NCT02546375View on ClinicalTrials.gov

A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

July 15, 2015

Primary Completion Date

January 16, 2017

Study Completion Date

January 16, 2017

Conditions
Chronic Myeloid Leukaemia
Interventions
DRUG

Bosutinib

Bosutinib 100mg film-coated tablets; Bosutinib 500mg film-coated tablets Dosage as prescribed at treating institution; (observational study)

Trial Locations (3)

L7 8XP

Royal Liverpool Hospital, Liverpool

W12 0HS

Hammersmith Hospital, London

NG5 1PB

Nottingham University Hospital, Nottingham

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
collaborator

pH Associates

UNKNOWN

lead

Pfizer

INDUSTRY

NCT02546375 - A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands | Biotech Hunter | Biotech Hunter